Back to Trials
NCT05470920NARecruiting

Genetic Testing Decision Aid

Massachusetts General Hospital

Start Date

10/14/2022

Completion Date

12/31/2026

Summary

This is a randomized trial to evaluate the effectiveness of an electronic decision aid tool versus a traditional genetic counselor session for multi-gene panel testing for people with ovarian or pancreatic cancer

Detailed Description

The research study procedures include: screening for eligibility and study questionnaires that would be performed in conjunction with either the genetic counselor visit or use of the electronic decision aid. The study questionnaires include: * Knowledge Survey * Shared Decision Making Process Survey * Decisional Conflict Scale The research study will last up to 2 weeks. It is expected that about 350 people will take part in this research study. The National Cancer Institute (NCI) is supporting this research study by providing funding for the research

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * 18 years or older * Being seen in clinic at Massachusetts General Hospital or Boston Medical Center * Diagnosed with malignant epithelial ovarian carcinoma or malignant pancreatic adenocarcinoma. Exclusion Criteria : * Unable or unwilling to provide informed consent, undergo randomization, or complete the surveys associated with the study * Previous germline genetic testing * History of hereditary pancreatitis * Members of the following vulnerable populations: adults unable to consent, individuals who are not yet adults

Interventions

BEHAVIORAL

Electronic Decision Aid

BEHAVIORAL

Pre-Test Genetic Counseling

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Epithelial Ovarian CarcinomaPancreas Adenocarcinoma

Locations

Massachusetts General Hospital

Boston, Massachusetts 02115

United States

Mass General at North Shore Cancer Center

Danvers, Massachusetts 01923

United States